BEAT - BioTelemetry Inc Stock Price, Fair Value and News

2.66USD+0.01 (+0.38%)Market Closed

Market Summary

USD2.66+0.01

Market Closed

0.38%

BEAT Stock Price

View Fullscreen

BEAT RSI Chart

BEAT Valuation

Market Cap

70.0M

Price/Earnings (Trailing)

-4.64

EV/EBITDA

-3.8

Price/Free Cashflow

-5.87

MarketCap/EBT

-4.64

BEAT Price/Sales (Trailing)

BEAT Profitability

Return on Equity

-120.51%

Return on Assets

-110.81%

Free Cashflow Yield

-17.04%

BEAT Fundamentals

BEAT Earnings

Earnings (TTM)

-15.1M

Earnings Growth (Yr)

-11.36%

Earnings Growth (Qtr)

-18.74%

Breaking Down BEAT Revenue

Last 7 days

-4.3%

Last 30 days

7.3%

Last 90 days

33%

Trailing 12 Months

-8.3%

How does BEAT drawdown profile look like?

BEAT Financial Health

BEAT Investor Care

Shares Dilution (1Y)

1.65%

Diluted EPS (TTM)

-0.49

About BioTelemetry Inc

HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

CEO	Dr. Branislav Vajdic Ph.D.
WEBSITE	heartbeam.com
INDUSTRY	Healthcare Plans
EMPLOYEES	10

BioTelemetry Inc Frequently Asked Questions

What is the ticker symbol for BioTelemetry Inc? What does BEAT stand for in stocks?

BEAT is the stock ticker symbol of BioTelemetry Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of BioTelemetry Inc (BEAT)?

As of Fri Jul 26 2024, market cap of BioTelemetry Inc is 70.04 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BEAT stock?

You can check BEAT's fair value in chart for subscribers.

Is BioTelemetry Inc a good stock to buy?

The fair value guage provides a quick view whether BEAT is over valued or under valued. Whether BioTelemetry Inc is cheap or expensive depends on the assumptions which impact BioTelemetry Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BEAT.